查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2020519

全球過敏診斷和治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Allergy Diagnostics And Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 146 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計過敏診斷和治療市場將從 2025 年的 454.8 億美元成長到 2034 年的 1,009.3 億美元，2026 年至 2034 年的複合年成長率為 9.26%。

由於氣喘、過敏性鼻炎、食物過敏和皮膚過敏等過敏性疾病的盛行率不斷上升，全球過敏診斷和治療市場正經歷強勁成長。過敏診斷測試有助於識別引發過敏反應的過敏原，使醫療專業人員能夠為患者制定合適的治療方案。

市場成長的促進因素包括日益嚴重的環境污染、生活方式的改變以及接觸過敏原的增加。分子過敏檢測等診斷技術的進步和檢測方法的改進提高了過敏檢測的準確性。此外，包括免疫療法和標靶治療在內的創新治療方法的開發，也改善了過敏性疾病的治療。

隨著全球對過敏管理的認知不斷提高，過敏診斷和治療市場預計將顯著成長。對過敏治療的持續研究、先進診斷工具的開發以及醫療基礎設施的擴張將推動市場成長。此外，對個人化治療方案日益成長的需求預計也將為該領域創造新的機會。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球過敏診斷與治療市場：按類型分類

  • 市場分析、洞察與預測
  • 診斷
  • 治療

第5章 全球過敏診斷與治療市場：依過敏原類型分類

  • 市場分析、洞察與預測
  • 食物
  • 吸入式
  • 製藥
  • 其他過敏原

第6章 全球過敏診斷與治療市場：依檢測類型分類

  • 市場分析、洞察與預測
  • 體內試驗
  • 體外檢查

第7章 全球過敏診斷與治療市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Pfizer Inc
    • AbbVie Inc
    • Sanofi
    • Thermo Fisher Scientific Inc
    • Siemens Healthineers
    • Danaher Corporation
    • Alcon
    • BioMerieux
    • EUROIMMUN Medizinische Labordiagnostika AG
    • AESKU.GROUP GmbH
    • DASIT Group SPA
    • Stallergenes Greer
    • HYCOR Biomedical
    • Minaris Medical America Inc
    • Allergy Therapeutics
簡介目錄
Product Code: VMR112115141

The Allergy Diagnostics And Treatment Market size is expected to reach USD 100.93 Billion in 2034 from USD 45.48 Billion (2025) growing at a CAGR of 9.26% during 2026-2034.

The global allergy diagnostics and treatment market is experiencing strong growth due to the increasing prevalence of allergic diseases such as asthma, allergic rhinitis, food allergies, and skin allergies. Allergy diagnostic tests help identify allergens that trigger allergic reactions, allowing healthcare providers to develop appropriate treatment plans for patients.

The market growth is driven by rising environmental pollution, changing lifestyles, and increasing exposure to allergens. Advances in diagnostic technologies, such as molecular allergy testing and improved laboratory testing methods, have enhanced the accuracy of allergy detection. Additionally, the development of innovative treatment options, including immunotherapy and targeted therapies, has improved the management of allergic conditions.

In the future, the allergy diagnostics and treatment market is expected to expand significantly as awareness about allergy management increases worldwide. Continued research in allergy treatment, the development of advanced diagnostic tools, and expanding healthcare infrastructure will support market growth. The rising demand for personalized treatment approaches is also expected to create new opportunities in this sector.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • Diagnostics
  • Therapeutics

By Allergen Type

  • Food
  • Inhaled
  • Drug
  • Other Allergens

By Test Type

  • In vivo Test
  • In vitro Test

COMPANIES PROFILED

  • Pfizer Inc, AbbVie Inc, Sanofi, Thermo Fisher Scientific Inc, Siemens Healthineers, Danaher Corporation, Alcon, bioMrieux, EUROIMMUN Medizinische Labordiagnostika AG, AESKUGROUP GmbH, DASIT Group SPA, Stallergenes Greer, HYCOR Biomedical, Minaris Medical America Inc, Allergy Therapeutics
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Therapeutics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET: BY ALLERGEN TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Allergen Type
  • 5.2. Food Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Inhaled Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Drug Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Other Allergens Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET: BY TEST TYPE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Test Type
  • 6.2. In vivo Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. In vitro Test Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET: BY REGION 2022-2034 (USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Type
    • 7.2.2 By Allergen Type
    • 7.2.3 By Test Type
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Type
    • 7.3.2 By Allergen Type
    • 7.3.3 By Test Type
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Type
    • 7.4.2 By Allergen Type
    • 7.4.3 By Test Type
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Type
    • 7.5.2 By Allergen Type
    • 7.5.3 By Test Type
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Type
    • 7.6.2 By Allergen Type
    • 7.6.3 By Test Type
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Pfizer Inc
    • 9.2.2 AbbVie Inc
    • 9.2.3 Sanofi
    • 9.2.4 Thermo Fisher Scientific Inc
    • 9.2.5 Siemens Healthineers
    • 9.2.6 Danaher Corporation
    • 9.2.7 Alcon
    • 9.2.8 BioMerieux
    • 9.2.9 EUROIMMUN Medizinische Labordiagnostika AG
    • 9.2.10 AESKU.GROUP GmbH
    • 9.2.11 DASIT Group SPA
    • 9.2.12 Stallergenes Greer
    • 9.2.13 HYCOR Biomedical
    • 9.2.14 Minaris Medical America Inc
    • 9.2.15 Allergy Therapeutics